BMCS 2nd Conformational Design in Drug Discovery 2025
Monday 3rd March – AstraZeneca, Cambridge, UK
This conference will combine advanced computational methods with experimental NMR and protein-ligand structural data to develop future medicines. The discussions will focus on ligand rigidification and optimization strategies for various innovative therapies, including protein-protein interaction inhibitors and PROTACs. Attendees will learn about successful case studies in conformational design, complementing other rational drug design efforts for improved medicine research.
Join Fabio Montisci, a Research and Applications Scientist at CCDC, for a presentation about
Data-Driven PROTAC Conformer Ensemble Generation and Docking.
Who Should Attend?
Medicinal chemists, computational chemists, structural biologists, biophysicists and NMR analytical chemists with an academic or industry interest in drug discovery.